Aetna stock: buy or sell?
November 28th, 2018
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions.
Should I buy Aetna stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading plan helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, 2 buy setups are elegible for Aetna stock right now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Aetna stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't detect any rating for AET stock for the last month.
Aetna stock analysis
Aetna shares set new all time highs again on November, marking to $213.36. Shares ended at $212.70 and remained steady 0.33%.
Aetna remained constant 0.33% to $212.70 after marking all time highs on November. AET shows a sign of strength in the short-term after finally breaking out above $210.90 on November and marking a new rising bottom. On October AET price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock.
Aetna shares escalated 3.57% late November 2018 and touched a new all time high at $213.36. Early November AET rocketed an impressive 5.33% in just one week.
Aetna stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, AET might consolidate in a flat-base, waiting to break out over or down under . Late October 2018 AET price bounced up over the SMA of 20 weeks that acted as support stopping new slides.
Aetna stock price history
Aetna stock went public on January 4th, 2018 with a price of $181.871. Since then, AET stock surged a 17.00%, with an average of 17.00% per year. If you had invested right after AET's IPO a $1,000 in Aetna stock in 2018, it would worth $170.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Aetna stock historical price chart
AET stock reached all-time highs on November with a price of $213.36.
Aetna stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' AET stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price prediction for Aetna stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareOn October, Aetna presented its financial report, posting a slightly fine growth for the Earnings per Share (EPS) ratio. Experts were expecting $2.84 per share, but Aetna posted $2.96. Aetna is reporting earnings for 2018-Q4 on January. We don't currently have any forecast for next quarter EPS ratio. Keep tuned in the coming weeks to learn about AET's EPS estimate.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2016, last anual revenues report draw an awful drop down of -4.15% to $60,535.00 M USD. When comparing 2017 vs 2016, however, profit margin (that is, the net income divided by revenues) stayed steady a -0.45% to 3.15%. Aetna presents anual results in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Aetna TTM sales up to September 2018 were $61,233.00 and income $3,665.00 M USD. If we compare this TTM figures with the last reported annuality, we can review Aetna business evolution since December 2017: Annual revenues up to September, compared to lastest yearly report, inched a tiny 1.15%. Regarding profit margin, Aetna stepped up 2.84% to 3.15%
|2013||$47,330 M||-||$1,910 M4.0%||-|
|2014||$58,003 M||22.55%||$2,041 M3.5%||6.85%|
|2015||$60,337 M||4.02%||$2,390 M4.0%||17.12%|
|2016||$63,155 M||4.67%||$2,271 M3.6%||-4.99%|
|2017||$60,535 M||-4.15%||$1,904 M3.1%||-16.16%|
|TTM||$61,233 M||1.15%||$3,665 M6.0%||92.49%|
Quarterly financial resultsAetna reported $15,484.00 million in revenues for 2018-Q3, a -0.49% decline compared to previous quarter. Reported quarter income marked $1,000.00 M with a profit margin of 6.46%. Profit margin declined a -1.33% compared to previous quarter when profit margin was 7.79%. When comparing turnover to same quarter last year, Aetna sales marked a beatiful gain and appreciated a 3.27%.
|2016-Q4||$15,750 M||-||$139 M0.9%||-|
|2017-Q1||$15,170 M||-3.68%||$-381 M-2.5%||-374.10%|
|2017-Q2||$15,520 M||2.31%||$1,200 M7.7%||-414.96%|
|2017-Q3||$14,994 M||-3.39%||$838 M5.6%||-30.17%|
|2017-Q4||$14,853 M||-0.94%||$244 M1.6%||-70.88%|
|2018-Q1||$15,335 M||3.25%||$1,209 M7.9%||395.49%|
|2018-Q2||$15,561 M||1.47%||$1,212 M7.8%||0.25%|
|2018-Q3||$15,484 M||-0.49%||$1,000 M6.5%||-17.49%|
Aetna ownershipWhen you are planning to invest in a company, it's always worth to review its ownership structure.
Aetna shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a of all shares.
The following table compares ownership indicators for other stocks related to Aetna:
|Market cap||$0.0 M|
|Total shares||0.0 M|
|Float shares||0.0 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Wednesday, November 28th, 2018|
|Day range||$211.79 - $213.36|
|Average true range||$2.52|
|50d mov avg||$203.39|
|100d mov avg||$199.24|
|200d mov avg||$0.00|
Aetna performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We compared Aetna against in the following table:
Aetna competitorsUnfortunately, we could not find any public company that could be defined as Aetna competitor. This doesn't mean Aetna does not have any competitor in the market, it's just we could not detected it.
Latest Aetna stock news
- InvestorPlaceAetna Uncertainty Is Keeping CVS Stock Way UndervaluedJune 17, 2019
- InvestorPlaceCan CVS Stock Overcome the Latest Wrench in Its Aetna Merger?June 13, 2019
- InvestorPlaceDoes Progress On Aetna Integration Make CVS Health Stock A Buy In May?May 21, 2019
- InvestorPlaceCVS Stock Faces Challenges With Aetna Merger … So Buy It!May 20, 2019
- InvestorPlaceAfter Aetna Merger, The Benefits Outweigh the Risks in CVS StockDecember 3, 2018